NicholasAButowskiMD

PubMed

• A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM].
  David Gibson, Anh Huan Vo, Hannah Lambing, Prithanjan Bhattacharya, Peggy Tahir, Farid F Chehab, Nicholas Butowski> ;BMC Neurology. 2024 Mar 23
• 1 citations
  "De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade.
  Hadad, S., Gupta, R., Oberheim Bush, N., Taylor, J., Villanueva-Meyer, J., Young, J., Wu, J., Ravindranathan, A., Zhang, Y., Warrier, G., McCoy, L., Shai, A., Pekmezci...> ;Acta Neuropathologica. 2023 Dec 11
• 2 citations
  Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.
  William C Chen, Abrar Choudhury, Mark W Youngblood, Mei-Yin C Polley, Calixto-Hope G Lucas, Kanish Mirchia, Sybren L N Maas, Abigail K Suwala, Minhee Won, James C Bayl...> ;Nature Medicine. 2023 Dec 1
• A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomas.
  Atsuro Saijo, Hirokazu Ogino, Nicholas A Butowski, Meghan R Tedesco, David Gibson, Payal B Watchmaker, Kaori Okada, Albert S Wang, Anny Shai, Andres M Salazar, Annette...> ;Neuro-Oncology. 2024 Feb 2
• 2 citations
  Quantitative analysis ofpromoter methylation in glioblastoma suggests nonlinear prognostic effect.
  David Gibson, Akshay Ravi, Eduardo Rodriguez, Susan Chang, Nancy Oberheim Bush, Jennie Taylor, Jennifer Clarke, David Solomon, Aaron Scheffler, John Witte, Hannah Lamb...> ;Neuro-Oncology Advances. 2023 Sep 19
• 2 citations
  Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.
  Raleigh, D., Chen, W., Choudhury, A., Youngblood, M., Polley, M., Lucas, C., Mirchia, K., Maas, S., Suwala, A., Won, M., Bayley, J., Harmanci, A., Harmanci, A., Klisch...> ;Research Square. 2023 Mar 20
• 10 citations
  Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial.
  John H Sampson, Achal Singh Achrol, Manish K Aghi, Krystof Bankiewicz, Martin Bexon, Steven Brem, Andrew Brenner, Chandtip Chandhasin, Sajeel Chowdhary, Melissa Coello...> ;Neuro-Oncology. 2023 Jun 2
• 31 citations
  Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade Glioma.
  Shawn L Hervey-Jumper, Yalan Zhang, Joanna J Phillips, Ramin A Morshed, Jacob S Young, Lucie McCoy, Marisa Lafontaine, Tracy Luks, Simon Ammanuel, Sofia Kakaizada, And...> ;Journal of Clinical Oncology. 2023 Apr 10
• 3 citations
  Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis).
  J Eduardo Rodriguez-Almaraz, Nicholas Butowski> ;Current Treatment Options in Oncology. 2023 Jan 1
• 2 citations
  A multicenter, phase 1, dose escalation clinical trial (G-FORCE-1) of XRT, RRx-001 and temozolomide followed by temozolomide +/- RRx-001 in newly diagnosed glioblastoma.
  Howard Fine, Tony Reid, Scott Caroen, Bryan Oronsky, Nacer Abrouk, Nicholas Butowski> ;Frontiers in Oncology. 2023 Jan 1
• 1 citations
  Novel intraoperative strategies for enhancing tumor control: Future directions.
  Alexander F Haddad, Manish K Aghi, Nicholas Butowski> ;Neuro-Oncology. 2022 Nov 2
• 9 citations
  Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.
  Calixto-Hope G Lucas, Emily A Sloan, Rohit Gupta, Jasper Wu, Drew Pratt, Harish N Vasudevan, Ajay Ravindranathan, Jairo Barreto, Erik A Williams, Anny Shai, Nicholas S...> ;Acta Neuropathologica. 2022 Oct 1
• 6 citations
  Intratumor and informatic heterogeneity influence meningioma molecular classification.
  Harish N Vasudevan, Abrar Choudhury, Stephanie Hilz, Javier E Villanueva-Meyer, William C Chen, Calixto-Hope G Lucas, Steve E Braunstein, Nancy Ann Oberheim Bush, Nich...> ;Acta Neuropathologica. 2022 Sep 1
• 24 citations
  Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study.
  Moran, S. E., Andrew B Lassman, Juan Manuel Sepúlveda-Sánchez, Timothy F Cloughesy, Miguel J Gil-Gil, Vinay K Puduvalli, Jeffrey J Raizer, Filip Y F De Vos, Patrick Y ...> ;Clinical Cancer Research. 2022 Jun 1
• 75 citations
  Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities.
  Abrar Choudhury, Stephen T Magill, Charlotte D Eaton, Briana C Prager, William C Chen, Martha A Cady, Kyounghee Seo, Calixto-Hope G Lucas, Tim J Casey-Clyde, Harish N ...> ;Nature Genetics. 2022 May 1
• 129 citations
  Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial.
  Antonio Omuro, Alba A Brandes, Antoine F Carpentier, Ahmed Idbaih, David A Reardon, Timothy Cloughesy, Ashley Sumrall, Joachim Baehring, Martin van den Bent, Oliver Bä...> ;Neuro-Oncology. 2023 Jan 5
• 9 citations
  Prospective genomically guided identification of "early/evolving" and "undersampled" IDH-wildtype glioblastoma leads to improved clinical outcomes.
  Yalan Zhang, Calixto-Hope G Lucas, Jacob S Young, Ramin A Morshed, Lucie McCoy, Nancy Ann Oberheim Bush, Jennie W Taylor, Mariza Daras, Nicholas A Butowski, Javier E V...> ;Neuro-Oncology. 2022 Oct 3
• 3 citations
  Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance).
  Evanthia Galanis, S Keith Anderson, Erin Twohy, Nicholas A Butowski, Adilia Hormigo, David Schiff, Antonio Omuro, Kurt A Jaeckle, Shaji Kumar, Timothy J Kaufmann, Susa...> ;Neuro-Oncology Advances. 2022 Apr 4
• 21 citations
  Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143.
  Antonio Omuro, David A Reardon, John H Sampson, Joachim Baehring, Solmaz Sahebjam, Timothy F Cloughesy, Alexandros-Georgios Chalamandaris, Von Potter, Nicholas Butowsk...> ;Neuro-Oncology Advances. 2022 Feb 26
• 25 citations
  Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas.
  Hirokazu Ogino, Jennie W Taylor, Takahide Nejo, David Gibson, Payal B Watchmaker, Kaori Okada, Atsuro Saijo, Meghan R Tedesco, Anny Shai, Cynthia M Wong, Jane E Rabbit...> ;The Journal of Clinical Investigation. 2022 Feb 1
• Recent advances in the molecular prognostication of meningiomas.
  Elaina J Wang, Alexander F Haddad, Jacob S Young, Ramin A Morshed, Joshua P H Wu, Diana M Salha, Nicholas Butowski, Manish K Aghi> ;Frontiers in Oncology. 2022 Jan 1
• 8 citations
  CDK 4/6 inhibitors for the treatment of meningioma.
  Jacob S Young, Reilly L Kidwell, Allison Zheng, Alex F Haddad, Manish K Aghi, David R Raleigh, Jessica D Schulte, Nicholas A Butowski> ;Frontiers in Oncology. 2022 Jan 1
• 15 citations
  Association of Neurological Impairment on the Relative Benefit of Maximal Extent of Resection in Chemoradiation-Treated Newly Diagnosed Isocitrate Dehydrogenase Wild-T...
  Alexander A Aabedi, Jacob S Young, Yalan Zhang, Simon Ammanuel, Ramin A Morshed, Cecilia Dalle Ore, Desmond Brown, Joanna J Phillips, Nancy Ann Oberheim Bush, Jennie W...> ;Neurosurgery. 2022 Jan 1
• 38 citations
  Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas.
  Yao Yu, Javier Villanueva-Meyer, Matthew R. Grimmer, Stephanie Hilz, David A. Solomon, Serah Choi, Michael Wahl, Tali Mazor, Chibo Hong, Anny Shai, Joanna J. Phillips,...> ;Neuro-Oncology. 2021 Nov 2
• 5 citations
  A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma.
  Nancy Ann Oberheim Bush, Jacob S. Young, Yalan Zhang, Cecilia L Dalle Ore, Annette M. Molinaro, Jennie Taylor, Jennifer Clarke, Michael D. Prados, Steve Braunstein, Da...> ;Journal of Neuro-Oncology. 2021 Jun 14
• Join now to see all

Journal Articles

• The Genetic Landscape of Gliomas Arising After Therapeutic Radiation  
  Iwei Yeh, Corey Raffel, Mitchel Berger, Joanna J Phillips, James P Grenert, Boris C Bastian, David A Solomon, Nicholas Butowski, Sabine Mueller, Cassie Kline, Manish A..., Acta Neuropathologica
• A Single-institution Phase II Trial of Radiation, Temozolomide, Erlotinib, and Bevacizumab for Initial Treatment of Glioblastoma  
  Clarke, J.L., Molinaro, A.M., Butowski, N.A., Chang, S.M., Phillips, J.J., Perry, A., Costello, J.F., DeSilva, A.A., Rabbitt, J.E., Prados, M.D., Neuro Oncol., 1/1/2014
• General and Neurological Complications of Targeted Therapy  
  Butowski NA, Chang SM, Handbook of Clinical Neurology, 1/1/2012
• Phase I Pharmacologic and Pharmacodynamic Study of the Gamma Secretase (Notch) Inhibitor MK-0752 in Adult Patients with Advanced Solid Tumors  
  Krop I, Demuth T, Guthrie T, Wen PY, Mason WP, Chinnaiyan P, et al., Journal of Clinical Oncology, 1/1/2012
• Individual Patient-specific Immunity against High-grade Glioma after Vaccination with Autologous Tumor Derived Peptides Bound to the 96 KD Chaperone Protein  
  Crane CA, Han SJ, Ahn BJ, Oehlke J, Kivett V, Butowski N, et al., Clinical Cancer Research, 1/1/2012
• Endpoints for Clinical Trials and Revised Assessment in Neurooncology  
  Butowski N, Chang SM, Current Opinion in Neurology, 1/1/2012
• Anti-angiogenic Therapy in Glioma  
  Butowski N, Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 1/1/2011
• Medical Management of Brain Metastases  
  Butowski N, Neurosurgery Clinics of North America, 1/1/2011
• Phase II and Pharmacogenomics Study of Enzastaurin plus Temozolomide during and following Radiation Therapy in Patients with Newly Diagnosed Glioblastoma Multiforme an...  
  Butowski N, Chang SM, Lamborn KR, Polley MY, Pieper R, Costello JF, et al., Neuro-oncology., 1/1/2011
• Identifying the Needs of Brain Tumor Patients and Their Caregivers  
  Parvataneni R, Polley MY, Freeman T, Lamborn K, Prados M, Butowski N, et al., Journal of Neuro-oncology, 1/1/2011
• Conditional Probability of Survival in Patients with Newly Diagnosed Glioblastoma  
  Polley MY, Lamborn KR, Chang SM, Butowski N, Clarke JL, Prados M, Journal of Clinical Oncology, 1/1/2011
• Anti-angiogenic Therapy in Glioma  
  Butowski N, Clinical & Translational Oncology, 1/1/2011
• Phase II and Pharmacogenomics Study of Enzastaurin plus Temozolomide during and following Radiation Therapy in Patients with Newly Diagnosed Glioblastoma Multiforme an...  
  Butowski N, Chang SM, Lamborn KR, Polley MY, Pieper R, Costello JF, et al., Neuro-oncology, 1/1/2011
• Immunostimulants for Malignant Gliomas  
  Butowski N, Neurosurgery Clinics of North America, 1/1/2010
• Recent Advances in Therapy for Glioblastoma  
  Clarke J, Butowski N, Chang S, Archives of Neurology, 1/1/2010
• Enzastaurin plus Temozolomide with Radiation Therapy in Glioblastoma Multiforme: A Phase I Study  
  Butowski N, Chang SM, Lamborn KR, Polley MY, Parvataneni R, Hristova-Kazmierski M, et al., Neuro-oncology, 1/1/2010
• Phase I Pharmakokinetic and Pharmacodynamic Study of Enzastaurin plus Temozolomide During and Following Radiation Therapy in Patients with Newly Diagnosed Glioblastoma...  
  Nicholas Butowski M.D.,Susan M. Chang M.D, Kathleen R. Lamborn Ph.D., Mei Yin Polley PhD. Michael D. Prados M.D., Neuro Oncol, 1/1/2010
• Phase II Study of Erlotinib plus Temozolomide during and after Radiation Therapy in Patients with Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma  
  Prados MD, Chang SM, Butowski N, DeBoer R, Parvataneni R, Carliner H, et al., Journal of Neuro-oncology, 1/1/2009
• Glial Tumors: The Current State of Scientific Knowledge  
  Butowski NA, Chang SM, Clinical Neurosurgery, 1/1/2006
• Diagnosis and Treatment of Recurrent High-grade Astrocytoma  
  Butowski NA, Sneed PK, Chang SM, Journal of Clinical Oncology, 1/1/2006
• Join now to see all

Books/Book Chapters

• Glioblastoma: Epidemiology, Risk Factors, Diagnosis, and Treatment Options 
  Butowski, NNova Publishers2011
• The Neurosurgeon's Handbook 
  Chapter: Neuro-Oncology 
  Butowski N, Liu R, Berger MEditors: George Samandouras.Oxford University Press2010
• Imaging of the Spine 
  Chapter: Managing the Tumor Patient 
  Butowski NEditors: Naidich T.Elsevier Press2010
• Cancer Neurology in Clinical Practice 
  Chapter: Metastases to the Peripheral Nervous System 
  Butowski NEditors: Kesari S.Humana Press2008
• Current Clinical Oncology 
  Chapter: Adult High Grade Glioma 
  Butowski N, Chang S2008
• Cancer Therapy 
  Chapter: Brain Cancer 
  Butowski N, Prados M, McDermott M, Chang SAndrews McNeel Publishing2008
• Neuro-Oncology: The Essentials 
  Chapter: Complications of Medical Therapy 
  Butowski N, Chang SEditors: Berger M.Thieme Inc2008
• Congress of Neurological Surgeons Handbook 
  Chapter: Current State of Brain Tumors 
  Butowski N, Chang S.2007
• Handbook of Brain Tumor Chemotherapy 
  Chapter: Clinical Trial Design and Implementation 
  Butowski N, Chang SEditors: Newton H.Elsevier Inc2006
• Join now to see all

Abstracts/Posters

• OMX-4.80 An Engineered Oxygen Carryig Protein Oxygenetes Hypoxic Tumors and Increase the Efficacy of Radiotherapy in Orthotopic Models of Glioblastoma
  Laura Serwer, Raquel Santos, Saharh Ng, Nicholas Butowski, Ana Krloitica, Tomoko OZawa, Stephen Cary, David James, World Federation of Neuro-Oncology Quadrennial Meeting, San Francisco, CA, 1/1/2014
• A Phase 2 Study of Orally Administered PLX3397 in Patients With Recurrent Glioblastoma
  N. Butowski, H. Colman, J. DeGroot A. Yung, A. Omuro, L. Nayak, T. Cloughsey, A. Marimuthu, A. Perry , J. Phillips , J. Joyce , B. L. West , M. Prados , K. Nolop, H..., ASCO Annual Meeting, 1/1/2014
• Phase I/II Study of Dianhydrogalactitol in Patients with Recurrent Malignant Glioblastoma Multiforme (GBM).
  Kent C. Shih, Manish R. Patel, Nicholas A. Butowski, Jeffrey A. Bacha, Dennis Brown, William J. Garner, Anne Steino, Richard Stephen Schwartz, Sarath Kanekal, Lorena L..., ASCO Annual Meeting, 1/1/2014
• Imaging Parameters and Molecular Correlates as Predictive Markers of Treatment Response to mTOR Inhibition in Adults with Recurrent Low-grade Gliomas
  Daphne Haas-Kogan, Joanna J. Phillips, Annette Molinaro, Michael Wahl, Sabine Mueller, William A. Weiss, Janine M. Lupo, Mitchel S. Berger, Michael Prados, Nicholas Bu..., AACR Annual Meeting, University of California, San Francisco, San Francisco, CA, 1/1/2013
• Development of Atypical and AnaplasticMeningiomaCell Resources: Results From Three Years Experience at UCSF
  C. David James, Nicholas Butowski, Rintaro Hashizume, Yu-Jen Lu, AriePerry, Andrew Parsa, and Michael McDermott, AANS Joint Section on Tumors Meningioma Session, 1/1/2013
• OMX-4.80 An Engineered Oxygen Carryig Protein Oxygenetes Hypoxic Tumors and Increase the Efficacy of Radiotherapy in Orthotopic Models of Glioblastoma
  Laura Serwer, Yasuyuki Yoshida, Natacha Le Moan, Raquel Santos, Sarah Ng, Nicholas Butowski, Ana Krtolica, Tomoko Ozawa, Stephen P.L. Cary, and C. David James, World Federation Meeting of Neuro-Oncology, San Francisco CA, 1/1/2013
• Dermatologic Event Characteristics and Management with the NovoTTF-100A System, a Novel Anti-Mitotic Device for the Treatment of Recurrent Glioblastoma (rGBM).
  M.E. Lacouture 1, M.E. Davis 1, G. Elzinga 2, N. Butowski 3, D. Tran 4, J.L. Villano 5, and E.T. Wong, World Federation Meeting of Neuro-Oncology, San Francisco CA, 1/1/2013
• Preclinical Evaluation of NT113, a Novel ERBB Inhibitor Optimiazed for CNS Distribution
  Y Yushida, T Ozawa, N Butowski, W Shen, D Brown, H Pedersen, C David James, World Federation Meeting of Neuro-oncology, San Francisco CA, 1/1/2013
• Comparison of Systemic versus Direct Intratumoral Administration of Nanoliposomal Irinotecan, with and without Fractionated Radiotherapy, for Efficacy in Treating Orth...
  Pin-Yuan Chen, Tomoko Ozawa, Daryl Drummond, Raquel Santos, ,Jacqueline D. Torre, Christina Ng, Edgar L. Lepe, Nicholas Butowski, Michael Prados, Krystof Bankiewicz, a..., SNO Annual Meeting, Washington DC, 1/1/2012
• A Comprehensive Evaluation of Cognition in Newly Diagnosed High-grade Glioma
  Caroline A. Racine, Janine M. Lupo, Annette Molinaro, Anna Parks, Susan/> M. Chang, Mitchel S. Berger, and Nicholas Butowski, SNO Annual Meeting, Washington DC, 1/1/2012
• Integrating physiological MRI with Assessment of Neurocognitve Function
  Janine M. Lupo, Caroline A. Racine, Angela Jakary, Annette Molinaro, Anna Parks, Susan M. Chang, Sarah J. Nelson, Mitchel S. Berger, and Nicholas Butowski, SNO Annual Meeting, 1/1/2012
• A Single-institution Phase II Trial of Radiation (RT), Temozolomide(TMZ), Erlotiniband Bevacizumabfor Initial Treatment of Glioblastoma(GBM)
  JL Clarke, MD, MPH, AM Molinaro, PhD, NA Butowski, MD, SM Chang, MD, JJ Phillips, MD, PhD, JF Costello, PhD, BM Costa, PhD, JE Rabbitt, RN, BSN, VA Kivett, BS, AA DeSi..., ASCO, 1/1/2012
• Autologous Heat Shock Protein Vaccine (HSPPC-96) For Patients with Recurrent Glioblastoma (GBM): Results of a Phase II Multicenter Clinical Trial with Immunological As...
  A. Parsa, C. Crane, S. Han, V. Kivett, A. Fedoroff, N. A. Butowski, S. M. Chang, J. L. Clarke, M. S. Berger, M. McDermott, M. Aghi, C. Yanes, M. Prados, A. E. Sloan, J..., ASCO Annual Meeting, Multiple locations, 1/1/2011
• Diffusion Imaging Parameters Vary with Treatment Regimen for Patients with Newly Diagnosed Glioblastoma Multiforme
  Laleh Jalilian, Emma Essock-Burns, Soonmee Cha, Susan Chang, Michael Prados, Nicholas Butowski, Sarah Nelson, SNO Annual Meeting, UCSF, San Francisco, CA, 2011; Anaheim,CA, 2011, 1/1/2011
• Can Susceptibility-Weighted Imaging Determine Response to Combined Anti-angiogenic, Cytotoxic, and Radiation Therapy in GBM Patients?
  J. M. Lupo , S. Cha, E. Essock-Burns, N. Butowski, and S. J. Nelson, International Society for Magnetic Resonance in Medicine, Sweden, 1/1/2010
• Comparison of DSC-derived Perfusion Parameters in Response to Conventional Therapy or Adjuvant Anti-angiogenic Therapy in Patients Newly-Diagnosed with GBM
  E. Essock-Burns, J. M. Lupo , S. Cha, N. Butowski, and S. J. Nelson, International Society for Magnetic Resonance in Medicine, Sweden, 1/1/2010
• Anatomic and Diffusion-weighted MR Imaging Characteristics of Recurrent Glioblastoma Multiforme Treated with Bevacizumab
  Kerlan, K., Chang, J.S., Barajas, R., Butowski, N., Cha, S., American Society of Neuroradiology Annual Meeting, Boston, MA, 1/1/2010
• Phase 2 Study of Enzastaurin plus Temozolomide during and following Radiation Therapy in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM) Or Gliosarcoma
  N. Butowski, K. Lamborn, S. Chang, D. Thornton, M. Page, Kivett, S. Nicol, M. Prados., American Society of Clinical Oncology Annual Meeting, Chicago, IL, 1/1/2010
• Assessment of Diffusion Parameters in Scans prior to Progression in GBM Patients following Antiangiogenic Therapy
  L. Jalilian, E. Essock-Burns, S. M. Chang, S. Cha, N. Butowski, and S. J. Nelson, American Society of Clinical Oncology Annual Meeting, Chicago, IL, 1/1/2010
• The Conditional Probability of Survival in Newly-diagnosed Glioblastoma Patients
  Mei-Yin C. Polley, Kathleen R. Lamborn, Susan M. Chang, Nicholas Butowski, Jennifer L. Clarke, and Michael Prados, Society of Neuro-Oncology Annual Meeting, Montreal, Canada, 1/1/2010
• Phase 2 Study of Enzastaurin plus Temozolomide during and following Radiation Therapy in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM) Or Gliosarcoma
  N. Butowski, K. Lamborn, S. Chang, D. Thornton, M. Page, Kivett, S. Nicol, M. Prados, American Academy of Neurology Annual Meeting, Chicago, IL, 1/1/2009
• Relationship between Early Perfusion Parameters Derived from DSC MR Imaging and Time-to-Progression in Patients with GBM Following Anti-Angiogenic Therapy
  Emma Essock-Burns, Janine M. Lupo, Soonmee Cha, Susan. M. Chang, Nicholas Butowski, Sarah J. Nelson, American Academy of Neurology Annual Meeting, Chicago, IL, 1/1/2009
• The Effect of Delaying Radiotherapy (RT) In Patients with Newly-diagnosed Glioblastoma Multiforme (GBM) Receiving Temozolomide (TMZ): A Secondary Analysis Based on the...
  N. Butowski, M Polley, K. Lamborn, S. Chang, J Clarke, P Sneed, K. Huang, M. Prados, Society of Neuro-Oncology Annual Meeting, New Orleans, LA, 1/1/2009
• Phase 1/2 Study of Enzastaurin plus Temozolomide during and following Radiation Therapy in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM) Or Gliosarcoma
  N. Butowski, K. Lamborn, S. Chang, D. Thornton, R. DeBoer, M. Page, J. Rabbitt, A. Fedoroff, R. Parvataneni, V. Kivett, S. Nicol, M. Prados, American Academy of Neurology Annual Meeting, Chicago, IL, 1/1/2008
• Phase 1/2 and PGx Study of Enzastaurin plus Temozolomide during and following Radiation Therapy in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM) Or Glios...
  N. Butowski, K. Lamborn, S. Chang, D. Thornton, R. DeBoer, M. Page, J. Rabbitt, A. Fedoroff, R. Parvataneni, V. Kivett, S. Nicol, M. Prados, American Society of Clinical Oncology Annual Meeting, Chicago, IL, 1/1/2008
• Join now to see all

Lectures

• DGM1 may serve as a novel genetic biomarker of response to enzastaurin in glioblastoma. 
  2019 ASCO Annual Meeting - 6/1/2019
• Overcoming Tumour Hypoxia to Enhance Patient Survival With a Tunable Oxygen-Binding Protein Therapy 
  United Kingdom - 1/1/2014
• ICBTRT: International Conference on Brain Tumor Research and Therapy 
  1/1/2014
• Mid Level Faculty Mentoring Seminar 
  1/1/2013
• Sunrise Session: Epilepsy in Patients with Brain Tumors 
  1/1/2013
• CNS Tumor Board Satellite Educational Series 
  1/1/2013
• Discussion of Hypoxia and Treatment Resistance in Glioblastoma 
  1/1/2013
• Preclinical Evaluation of NT113, a Novel ERBB Inhibitor Optimized for CNS Biodistribution 
  1/1/2013
• Reversing Hypoxia In Glioblastoma 
  1/1/2013
• Contemporary Management of Glioblastoma 
  1/1/2013
• Hypoxia In Glioblastoma 
  United Kingdom - 1/1/2012
• I Seve Ballesteros Foundation Translational Neuro-oncology Summit 
  Madrid, Spain - 1/1/2010
• Phase II and Pharmacogenomics (PGx) Study of Enzastaurin (ENZ) plus Temozolomide (TMZ) and Radiation Therapy (RT) in Patients with Glioblastoma Multiforme (GBM) or Gli... 
  New Orleans, LA - 1/1/2009
• Meningioma Update 
  1/1/2009
• Phase I/II and Pharmacogenomics (PGx) Study of Enzastaurin (ENZ) plus Temozolomide (TMZ) and Radiation Therapy (RT) in Patients with Glioblastoma Multiforme (GBM) or G... 
  Barcelona, Spain - 1/1/2008
• Revolution Health Education Talk 
  1/1/2006
• Newly Diagnosed GBM: Proton MR Spectroscopic Characteristics and Correlation with Clinical Outcome 
  Edinburgh, Scotland - 1/1/2005
• Join now to see all